Patient‐Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019. (9th June 2020)

• Record Type: Journal Article
• Authors: Bhatnagar, Vishal; Hudgens, Stacie; Piault‐Louis, Elisabeth; Jones, Lee; Beaver, Julia A.; Lyerly, H. Kim; Reaman, Gregory; Fleming, Thomas; Kluetz, Paul G.
• Is Part Of: Oncologist. Volume 25:Number 10(2020)
• Page Start: 819
• Page End: 821
• Publication Date: 2020-06-09
• Subjects: Patient‐reported outcome measures -- Clinical trials; Oncology -- Periodicals; Tumors -- Periodicals; Cancérologie -- Périodiques; Tumeurs -- Périodiques; Oncology; Tumors; Neoplasms; Electronic journals; Periodicals; Periodicals; 616.994
• DOI: 10.1634/theoncologist.2020-0062
• Languages: English
• ISSNs: 1083-7159

Abstract

Abstract : The measurement and analysis of patient‐reported outcomes is important in cancer clinical trials. This commentary reports advances and challenges from presentations at the 2019 Accelerating Anticancer Agent Development and Validation (AAADV) Workshop Patient‐Reported Outcomes Session.